Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipientsCentral MessagePerspective

Objective: Heart transplants (HTs) from hepatitis C virus (HCV)-viremic donors to HCV-seronegative recipients (HCV D+/R–) have good 6-month outcomes, but practice uptake and long-term outcomes overall and among candidates on mechanical circulatory support (MCS) have yet to be established. Methods: U...

Full description

Bibliographic Details
Main Authors: Jessica M. Ruck, MD, Alice L. Zhou, MS, Laura B. Zeiser, ScM, Diane Alejo, BA, Christine M. Durand, MD, Allan B. Massie, PhD, MHS, Dorry L. Segev, MD, PhD, Errol L. Bush, MD, Ahmet Kilic, MD
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:JTCVS Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273622003722